1.
PLOS ONE 7 : 7 Paper: e39485 , 17 p. (2012)
Közlemény:2034805 Egyeztetett Forrás Idéző Folyóiratcikk (Szakcikk ) Nyilvános idézők összesen: 36 Független: 22 Függő: 14 Idézett közlemények száma: 4
Folyóiratcikk/Szakcikk (Folyóiratcikk)/Tudományos[2034805] [Érvényesített]
Független idéző: 22, Függő idéző: 14, Nem vizsgált idéző: 0, Összes idéző: 36
  1. * Szolnoki E et al. Foldameric β-H18/20P mixed helix stabilized by head-to-tail contacts: A way to higher-order structures Foldameric-H18/20P Mixed Helix Stabilized by Head-to-Tail Contacts: A Way to Higher-Order Structures. (2013) EUROPEAN JOURNAL OF ORGANIC CHEMISTRY 1434-193X 1099-0690 2013 17 3555-3559
  2. Rodríguez-Vázquez N et al. Synthesis of cyclic γ-amino acids for foldamers and peptide nanotubes. (2013) EUROPEAN JOURNAL OF ORGANIC CHEMISTRY 1434-193X 1099-0690 17 3477-3493
  3. * Varga E et al. Abeta(1-42) Enhances Neuronal Excitability in the CA1 via NR2B Subunit-Containing NMDA Receptors. (2014) NEURAL PLASTICITY 2090-5904 1687-5443 2014
  4. * I M Mandity et al. Continuous-Flow Solid-Phase Peptide Synthesis: A Revolutionary Reduction of the Amino Acid Excess. (2014) CHEMSUSCHEM 1864-5631 1864-564X 7 11 3172-3176
  5. * Mándity IM et al. Exploiting aromatic interactions for β-peptide foldamer helix stabilization: A significant design element. (2014) CHEMISTRY-A EUROPEAN JOURNAL 0947-6539 1521-3765 20 16 4591-4597
  6. Ruozi B et al. Nanotechnology and Alzheimer's Disease: What has been Done and What to Do'. (2014) CURRENT MEDICINAL CHEMISTRY 0929-8673 1875-533X 21 36 4169-4185
  7. * Cabrele C et al. Peptides containing β-amino acid patterns: Challenges and successes in medicinal chemistry. (2014) JOURNAL OF MEDICINAL CHEMISTRY 0022-2623 1520-4804 57 23 9718-9739
  8. * Nemeth LJ et al. Predicting Order and Disorder for β-Peptide Foldamers in Water. (2014) JOURNAL OF CHEMICAL INFORMATION AND MODELING 1549-9596 1549-960X 54 10 2776-2783
  9. Matthew Stephen. Propagation of Oligomeric α-Synuclein and Amyloid-β: Implications for Parkinson's and Alzheimer's Diseases. (2014)
  10. Burslem George M et al. Synthesis of Oligobenzamide α-Helix Mimetics. (2014) SYNLETT 0936-5214 1437-2096 25 03 324-335
  11. * Varga E et al. Amyloid-beta1-42 Disrupts Synaptic Plasticity by Altering Glutamate Recycling at the Synapse. (2015) JOURNAL OF ALZHEIMER'S DISEASE 1387-2877 1875-8908 45 2 449-456
  12. * István M Mándity et al. An overview of peptide and peptoid foldamers in medicinal chemistry. (2015) EXPERT OPINION ON DRUG DISCOVERY 1746-0441 1746-045X 10 11 1163-1177
  13. Wolfenden Mark et al. Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3. (2015) MOLECULES 1420-3049 20 4 7059-7096
  14. Barnard A et al. Multivalent helix mimetics for PPI-inhibition. (2015) ORGANIC & BIOMOLECULAR CHEMISTRY 1477-0520 1477-0539 13 1 258-264
  15. Chemerovski-Glikman Marina et al. New Perspectives in Reducing Amyloid Aggregation and Toxicity. (2015) ISRAEL JOURNAL OF CHEMISTRY 0021-2148 55 6-7 735-748
  16. Derrick JS et al. Tools of the Trade: Investigations into Design Strategies of Small Molecules to Target Components in Alzheimer's Disease. (2015) CHEMBIOCHEM 1439-4227 1439-7633 16 6 887-898
  17. Grison Claire M et al. An -Helix-Mimicking 12,13-Helix: Designed //-Foldamers as Selective Inhibitors of Protein-Protein Interactions. (2016) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 1433-7851 1521-3773 55 Seville 11096-11100
  18. Grison Claire M. et al. An -Helix-Mimicking 12,13-Helix: Designed//-Foldamers as Selective Inhibitors of Protein-Protein Interactions. (2016) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 1433-7851 1521-3773 55 37 11096-11100
  19. Hong-Ji Sun et al. Efficient GSH delivery using PAMAM-GSH into MPP-induced PC12 cellular model for Parkinson’s disease. (2016) Regenerative Biomaterials 2056-3418 2056-3426 3 5 299-307
  20. Szefczyk Monika et al. Controlling the Helix Handedness of alpha alpha beta-Peptide Foldamers through Sequence Shifting. (2017) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 1433-7851 1521-3773 56 8 2087-2091
  21. Szefczyk M et al. Controlling the Helix Handedness of ααβ-Peptide Foldamers through Sequence Shifting. (2017) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 1433-7851 1521-3773 56 8 2087-2091
  22. * Bartus E et al. De Novo Modular Development of a Foldameric Protein-Protein Interaction Inhibitor for Separate Hot Spots: A Dynamic Covalent Assembly Approach. (2017) CHEMISTRYOPEN 2191-1363 6 2 236-241
  23. * Bartus Eva et al. De Novo Modular Development of a Foldameric Protein-Protein Interaction Inhibitor for Separate Hot Spots: A Dynamic Covalent Assembly Approach. (2017)
  24. * Mandity IM et al. Homochirality of beta-Peptides: A Significant Biomimetic Property of Unnatural Systems. (2017) CHEMISTRYOPEN 2191-1363 6 4 492-496
  25. Hegedüs Zsófia. Molecular mimicry of conformationally diverse β-sheets by using α/β-peptide foldamers. (2017)
  26. * Hegedüs Z et al. Molecular Recognition Using Foldamers. (2017) Megjelent: Comprehensive Supramolecular Chemistry II pp. 511-537
  27. * Olajos Gábor et al. Multivalent foldamer-based affinity assay for selective recognition of Aβ oligomers. (2017) ANALYTICA CHIMICA ACTA 0003-2670 1873-4324 960 131-137
  28. Young LM et al. Small molecule probes of protein aggregation. (2017) CURRENT OPINION IN CHEMICAL BIOLOGY 1367-5931 1879-0402 39 90-99
  29. Saraogi I et al. Supramolecular Assemblies in Chemical Biology. (2017) Megjelent: Comprehensive Supramolecular Chemistry II pp. 3-37
  30. Leiro Victoria et al. Dendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful Nanomedicine. (2018) ADVANCED FUNCTIONAL MATERIALS 1616-301X 1616-3028 28 12
  31. de Araujo Renan Vinicius et al. New Advances in General Biomedical Applications of PAMAM Dendrimers. (2018) MOLECULES 1420-3049 23 11
  32. * Bartus É. et al. Structural optimization of foldamer-dendrimer conjugates as multivalent agents against the toxic effects of amyloid beta oligomers. (2018) MOLECULES 1420-3049 1420-3049 23 10
  33. de la Torre Cristina et al. The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer's Disease Therapeutics and Diagnostics. (2018) PHARMACEUTICS 1999-4923 10 4
  34. Han Jiyeon et al. Tuning Structures and Properties for Developing Novel Chemical Tools toward Distinct Pathogenic Elements in Alzheimer's Disease. (2018) ACS CHEMICAL NEUROSCIENCE 1948-7193 9 4 800-808
  35. Bors Luca et al. Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery. (2019) SCIENTIA PHARMACEUTICA 0036-8709 2218-0532 87 1 p. 6
  36. Laxio Arenas J. et al. Peptides and peptidomimetics as inhibitors of protein–protein interactions involving β-sheet secondary structures. (2019) CURRENT OPINION IN CHEMICAL BIOLOGY 1367-5931 1879-0402 52 157-167
2020-10-21 12:12